Cargando…

Tixagevimab and cilgavimab for COVID-19 prophylaxis

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584788/
https://www.ncbi.nlm.nih.gov/pubmed/36382164
http://dx.doi.org/10.18773/austprescr.2022.058
_version_ 1784813350094372864
collection PubMed
description
format Online
Article
Text
id pubmed-9584788
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-95847882022-11-14 Tixagevimab and cilgavimab for COVID-19 prophylaxis Aust Prescr New Drugs NPS MedicineWise 2022-09-01 2022-10 /pmc/articles/PMC9584788/ /pubmed/36382164 http://dx.doi.org/10.18773/austprescr.2022.058 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drugs
Tixagevimab and cilgavimab for COVID-19 prophylaxis
title Tixagevimab and cilgavimab for COVID-19 prophylaxis
title_full Tixagevimab and cilgavimab for COVID-19 prophylaxis
title_fullStr Tixagevimab and cilgavimab for COVID-19 prophylaxis
title_full_unstemmed Tixagevimab and cilgavimab for COVID-19 prophylaxis
title_short Tixagevimab and cilgavimab for COVID-19 prophylaxis
title_sort tixagevimab and cilgavimab for covid-19 prophylaxis
topic New Drugs
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584788/
https://www.ncbi.nlm.nih.gov/pubmed/36382164
http://dx.doi.org/10.18773/austprescr.2022.058